You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 776 to 800 of about 5880
Next 25
12/01/2020
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
11/30/2020
OncoSynergy Opens Enrollment for Clinical Trial of New Cancer Antibody Therapy, OS2966, in Patients with Recurrent Glioblastoma
Al Musella`s Thoughts on the SNO 2020 Conference!
11/26/2020
2020 UCLA Brain Tumor Virtual Conference
11/23/2020
New version of NCCN Guidelines for CNS Cancers
Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial
11/22/2020
Brain tumor patients get to interview celebrities!
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
DNAtrix Announces Positive Data from Phase 2 CAPTIVE (KEYNOTE-192) Study with DNX-2401 in Patients with Recurrent Glioblastoma Highlighted in an Oral Late-Breaking Presentation During Society for Neuro-oncology (SNO) Annual Meeting
11/20/2020
PLUS THERAPEUTICS ANNOUNCES POSITIVE INTERIM DATA FROM RESPECT™ PHASE 1 CLINICAL TRIAL IN RECURRENT GLIOBLASTOMA
11/19/2020
Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting
NX Development Corp. (NXDC) Launches Gleolan (aminolevulinic acid HCl) Meningioma Phase III Clinical Trial (NXDC-MEN-301)
11/17/2020
xCures launches xACCESS - A new module in their AI-assisted clinical platform
PLUS THERAPEUTICS ANNOUNCES WEBINAR TO PRESENT RESPECT™ GLIOBLASTOMA CLINICAL TRIAL UPDATE
11/15/2020
Clinical Characteristics of High-Grade Glioma with Primary Leptomeningeal Seeding at Initial Diagnosis in a Single Center Study
11/13/2020
GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors
11/12/2020
Novocure: A Disruptive Growth Play In Cancer Treatments
11/10/2020
Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series
11/05/2020
First Patient Treated With Experimental Therapy For Deadly Childhood Brain Cancer
Oncoceutics Receives Foundation Grants to Establish an Expanded Access Program for ONC201
11/04/2020
ANNOUNCING THE LAUNCH OF OUR NEW WEBSITE AND CHANGE OF DOMAIN NAME FROM .Com to .Org
Problem With News Blast Yesterday
11/03/2020
Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma